Jason Riggs, AuD, PhD

Associate Director, Clinical Sciences
Regeneron Pharmaceuticals, Inc.
Tarrytown, New York

Jason Riggs, AuD, PhD, is an Associate Director, Clinical Scientist at Regeneron Pharmaceuticals. He currently develops gene therapy–related clinical trials for children with genetic-related hearing loss. He is a graduate of the Northeast Ohio Au.D. Consortium (NOAC) as well as The Ohio State University.

Presentation(s):

• MM208 - Congenital Hearing Loss: Gene Therapy and an Update on the CHORD Clinical Trial

  Thursday, March 27, 2025
  5:00 PM - 5:30 PM CST

  Disclosure(s): Financial: Regeneron Pharmaceuticals, Inc.: Employment (Ongoing), Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Nonfinancial: No nonfinancial relationships to disclose